Streptolysin S-like virulence factors: The continuing sagA

Nature Reviews Microbiology

Volumn 9, Issue 9, 2011, Pages 670-681

  Molloy, Evelyn M ^a   Cotter, Paul D ^b,c   Hill, Colin ^a,b   Mitchell, Douglas A ^a   Ross, R Paul ^b,d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LISTERIOLYSIN; OXAZOLE; PEPTIDE; SAGA ANTIGEN; STREPTOLYSIN S; THIAZOLE; VIRULENCE FACTOR;

ANTIGEN FUNCTION; BIOCHEMISTRY; CLOSTRIDIA; GENETIC IDENTIFICATION; LISTERIA MONOCYTOGENES; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A;

BACTERIAL PROTEINS; HUMANS; OPERON; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE;

CLOSTRIDIUM BOTULINUM; LISTERIA MONOCYTOGENES; POSIBACTERIA; STREPTOCOCCUS PYOGENES;

EID: 80051802504     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2624     Document Type: Review

References (160)

1. Lancefield, R. C. A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 57, 571-595 (1933). The original report of the now-standard classification technique based on specific carbohydrate 'group' antigens that are associated with the β-haemolytic streptococci.
2. Facklam, R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 15, 613-630 (2002). A review covering changes in the nomenclature and taxonomy of the genus Streptococcus, arising from the additional use of genetic comparisons in the classification of the different species. (Pubitemid 41184081)
3. Cunningham, M. W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13, 470-511 (2000). (Pubitemid 30452618)
4. Efstratiou, A. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45(Suppl. 1), 3-12 (2000). (Pubitemid 30093616)
5. Stevens, D. L. The flesh-eating bacterium: what's next? J. Infect. Dis. 179, S366-S374 (1999).
6. O'Loughlin, R. E. et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45, 853-862 (2007). (Pubitemid 47580376)
7. Ben-Abraham, R. et al. Invasive group A streptococcal infections in a large tertiary center: epidemiology, characteristics and outcome. Infection 30, 81-85 (2002). (Pubitemid 34293371)
8. O'Brien, K. L. et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35, 268-276 (2002). (Pubitemid 34800274)
9. WHO. The current evidence for the burden of group A streptococcal diseases. WHO [online], http://www.who. int/child-adolescent-health/documents/ fch-cah-05-07/en/index.html (2005).
10. Centor, R. M., Meier, F. A. & Dalton, H. P. Throat cultures and rapid tests for diagnosis of group A streptococcal pharyngitis. Ann. Intern. Med. 105, 892-899 (1986). (Pubitemid 17201770)
11. Brown, J. H. The Use of Blood Agar for the Study of Streptococci. (The Rockefeller Institute for Medical Research, New York, 1919).
12. Taranta, A., Moody, M. D. Diagnosis of streptococcal pharyngitis and rheumatic fever. Pediatr. Clin. North Am. 18, 125-143 (1971).
13. Marmorek, A. Le streptocoque et le sérum antistreptococcique. Ann. Inst. Pasteur 9, 593-620 (1895) (in French).
14. Marmorek, A. L'Unité des streptocoques pathogènes pour l'homme. Ann. Inst. Pasteur 16, 172 (1902) (in French).
15. Todd, E. W. The differentiation of two distinct serologic varieties of streptolysin, streptolysin O and streptolysin S. J. Pathol. Bacteriol. 47, 423-445 (1938). The paper that established that GAS produces two distinct haemolysins, one designated SLO to indicate its sensitivity to oxygen and another, an oxygen-stable haemolysin, designated SLS because of its high solubility in serum.
16. McCormick, J. K., Peterson, M. L. & Schlievert, P. M. in Gram-Positive Pathogens 2nd edn (eds Fischetti, V. A. et al.) 47-58 (American Society for Microbiology Press, Washington DC, 2006).
17. Halbert, S. P. Streptolysin O. Microb. Toxins 3, 69-98 (1970).
18. De Azavedo, J. C., Salim, K. Y. & Bast, D. J. in The Comprehensive Sourcebook of Bacterial Protein Toxins (eds Alouf, J. E. & Popoff, M. R.) 728-736 (Academic Press, San Diego, 2006).
19. Datta, V. et al. Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol. Microbiol. 56, 681-695 (2005). Work showing that the sagABCDEFG genes in the sag operon are each required for the expression of functional SLS, and providing support for the designation of SLS as a bacteriocin-like toxin. (Pubitemid 40562362)
20. Lee, S. W. et al. Discovery of a widely distributed toxin biosynthetic gene cluster. Proc. Natl Acad. Sci. USA 105, 5879-5884 (2008). A study demonstrating that, after modification by in vitro reconstitution, SagA is converted into a cytolysin; this article provides the first molecular-level description of the factor that is responsible for the β-haemolytic phenotype of GAS. (Pubitemid 351758466)
21. Alouf, J. E. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol. Ther. 11, 661-717 (1980). (Pubitemid 11164502)
22. Theodore, T. S. & Calandra, G. B. Streptolysin S activation by lipoteichoic acid. Infect. Immun. 33, 326-328 (1981). (Pubitemid 11066063)
23. Ginsburg, I. Is streptolysin S of group A streptococci a virulence factor? APMIS 107, 1051-1059 (1999). (Pubitemid 30016629)
24. Keiser, H., Weissmann, G. & Bernheimer, A. W. Studies on lysosomes. IV. Solubilization of enzymes during mitochondrial swelling and disruption of lysosomes by streptolysin S and other hemolytic agents. J. Cell Biol. 22, 101-113 (1964).
25. Hryniewicz, W. & Pryjma, J. Effect of streptolysin S on human and mouse T and B lymphocytes. Infect. Immun. 16, 730-733 (1977). (Pubitemid 8112735)
26. Bernheimer, A. W. & Schwartz, L. L. Lysosomal disruption by bacterial toxins. J. Bacteriol. 87, 1100-1104 (1964).
27. Bernheimer, A. W. & Schwartz, L. L. Effect of staphylococcal and other bacterial toxins on platelets in vitro. J. Pathol. Bacteriol. 89, 209-223 (1965).
28. Bernheimer, A. W. Disruption of wall-less bacteria by streptococcal and staphylococcal toxins. J. Bacteriol. 91, 1677-1680 (1966).
29. Roggiani, M., Assimacopoulos, A. P. & Schlievert, P. M. in Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis (eds Stevens, D. L. & Kaplan, E. L.) 57-75 (Oxford Univ. Press, New York, 2000).
30. Nizet, V. Streptococcal β-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol. 10, 575-580 (2002). (Pubitemid 36139879)
31. Ofek, I., Bergner-Rabinowitz, S. & Ginsburg, I. Oxygen-stable hemolysins of group A streptococci. VIII. Leukotoxic and antiphagocytic effects of streptolysins S and O. Infect. Immun. 6, 459-464 (1972).
32. Carr, A., Sledjeski, D. D., Podbielski, A., Boyle, M. D. & Kreikemeyer, B. Similarities between complementmediated and streptolysin S-mediated hemolysis. J. Biol. Chem. 276, 41790-41796 (2001).
33. Loridan, C. & Alouf, J. E. Purification of RNA-core induced streptolysin S, and isolation and haemolytic characteristics of the carrier-free toxin. J. Gen. Microbiol. 132, 307-315 (1986). (Pubitemid 16123845)
34. Borgia, S. M., Betschel, S., Low, D. E. & de Azavedo, J. C. Cloning of a chromosomal region responsible for streptolysin S production in Streptococcus pyogenes. Ad v. Exp. Med. Biol. 418, 733-736 (1997). (Pubitemid 27438534)
35. Betschel, S. D., Borgia, S. M., Barg, N. L., Low, D. E. & De Azavedo, J. C. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect. Immun. 66, 1671-1679 (1998). After more than a century of research into the β-haemolytic phenotype of GAS, this study reports the discovery of a potential genetic determinant involved in SLS production: sagA, a gene that encodes a small peptide of 53 amino acids. (Pubitemid 128471534)
36. Nizet, V. et al. Genetic locus for streptolysin S production by group A Streptococcus. Infect. Immun. 68, 4245-4254 (2000). Research characterizing the nine-gene sag operon that is involved in SLS production. (Pubitemid 30434580)
37. Ferretti, J. J. et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl Acad. Sci. USA, 98, 4658-4663 (2001). (Pubitemid 32295032)
38. Cotter, P. D., Hill, C. & Ross, R. P. Bacteriocins: developing innate immunity for food. Nature Rev. Microbiol. 3, 777-788 (2005). (Pubitemid 41518738)
39. Oman, T. J. & van der Donk, W. A. Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nature Chem. Biol. 6, 9-18 (2010).
40. Nes, I. F. & Tagg, J. R. Novel lantibiotics and their pre-peptides. Antonie Van Leeuwenhoek 69, 89-97 (1996). (Pubitemid 26060716)
41. Cox, C. R., Coburn, P. S. & Gilmore, M. S. Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr. Protein Pept. Sci. 6, 77-84 (2005). (Pubitemid 40259803)
42. McAuliffe, O., Ross, R. P. & Hill, C. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25, 285-308 (2001). (Pubitemid 32429585)
43. Jack, R. W., Tagg, J. R. & Ray, B. Bacteriocins of grampositive bacteria. Microbiol. Rev. 59, 171-200 (1995).
44. Yorgey, P., Davagnino, J. & Kolter, R. The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase. Mol. Microbiol. 9, 897-905 (1993). (Pubitemid 23253513)
45. Li, Y. M., Milne, J. C., Madison, L. L., Kolter, R. & Walsh, C. T. From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase. Science 274, 1188-1193 (1996). This investigation determines that the MccB17-asscociated cyclodehydratase, dehydrogenase and docking protein form a complex and act collectively to install thiazoles and oxazoles onto the inactive precursor; the work also highlights the importance of the leader peptide. (Pubitemid 26389284)
46. Millan, J. L. S., Kolter, R. & Moreno, F. Plasmid genes required for microcin-B17 production. J. Bacteriol. 163, 1016-1020 (1985). (Pubitemid 15230735)
47. Yorgey, P. et al. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc. Natl Acad. Sci. USA 91, 4519-4523 (1994). (Pubitemid 24143465)
48. Milne, J. C. et al. Cofactor requirements and reconstitution of microcin B17 synthetase: a multienzyme complex that catalyzes the formation of oxazoles and thiazoles in the antibiotic microcin B17. Biochemistry 38, 4768-4781 (1999).
49. Mitchell, D. A. et al. Structural and functional dissection of the heterocyclic peptide cytotoxin streptolysin S. J. Biol. Chem. 284, 13004-13012 (2009). A paper providing the first steps towards the elucidation of the SLS structure, and describing the identification of the requisite features of SagBCD substrate recognition and SagA residues of functional importance.
50. Haft, D. H., Basu, M. K. & Mitchell, D. A. Expansion of ribosomally produced natural products: a nitrile hydratase-and Nif11-related precursor family. BMC Biol. 8, 70 (2010). As well as uniting numerous TOMM biosynthesis gene clusters with their cognate substrates, this study defines the TOMM family of natural products.
51. Gonzalez, D. J. et al. Clostridiolysin S: a posttranslationally modified biotoxin from Clostridium botulinum. J. Biol. Chem. 285, 28220-28228 (2010).
52. Nakai, K. & Horton, P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem. Sci. 24, 34-36 (1999).
53. Sahl, H. G. & Bierbaum, G. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu. R ev. Microbiol. 52, 41-79 (1998). (Pubitemid 28481187)
54. Meier, F. A., Centor, R. M., Graham, L. Jr & Dalton, H. P. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci. Arch. Intern. Med. 150, 825-829 (1990). (Pubitemid 20122059)
55. Turner, J. C., Hayden, F. G., Lobo, M. C., Ramirez, C. E. & Murren, D. Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students. J. Clin. Microbiol. 35, 1-4 (1997). (Pubitemid 26422619)
56. Lindbaek, M., Hoiby, E. A., Lermark, G., Steinsholt, I. M. & Hjortdahl, P. Clinical symptoms and signs in sore throat patients with large colony variant β-haemolytic streptococci groups C or G versus group A. Br. J. Gen. Pract. 55, 615-619 (2005). (Pubitemid 41149830)
57. Humar, D. et al. Streptolysin S and necrotising infections produced by group G Streptococcus. Lancet 359, 124-129 (2002). (Pubitemid 34112541)
58. Hashikawa, S. et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J. Clin. Microbiol. 42, 186-192 (2004). (Pubitemid 38082718)
59. McNulty, S. T., Klesius, P. H., Shoemaker, C. A. & Evans, J. J. Streptococcus iniae infection and tissue distribution in hybrid striped bass (Morone chrysops x Morone saxatilis) following inoculation of the gills. Aquaculture 220, 165-173 (2003). (Pubitemid 36405391)
60. Weinstein, M. R. et al. Invasive infections due to a fish pathogen, Streptococcus iniae. N. Engl. J. Med. 337, 589-594 (1997). (Pubitemid 27360758)
61. Facklam, R., Elliott, J., Shewmaker, L. & Reingold, A. Identification and characterization of sporadic isolates of Streptococcus iniae isolated from humans. J. Clin. Microbiol. 43, 933-937 (2005). (Pubitemid 40256065)
62. Fuller, J. D. et al. Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect. Immun. 70, 5730-5739 (2002).
63. Locke, J. B. et al. Streptococcus iniae β-hemolysin streptolysin S is a virulence factor in fish infection. Dis. Aquat. Organ. 76, 17-26 (2007). (Pubitemid 47025889)
64. Timoney, J. F. The pathogenic equine streptococci. Vet. Res. 35, 397-409 (2004). (Pubitemid 39161930)
65. Flanagan, J. et al. Characterization of the haemolytic activity of Streptococcus equi. Microb. Pathog. 24, 211-221 (1998). (Pubitemid 28180049)
66. Yoshino, M. et al. Nonhemolytic Streptococcus pyogenes isolates that lack large regions of the sag operon mediating streptolysin S production. J. Clin. Microbiol. 48, 635-638 (2010).
67. James, L. & McFarland, R. B. An epidemic of pharyngitis due to a nonhemolytic group A Streptococcus at Lowry Air Force Base. N. Engl. J. Med. 284, 750-752 (1971).
68. Turner, D. P. & Gunn, S. L. Fatal case of sepsis caused by a non-haemolytic strain of Streptococcus pyogenes. J. Clin. Pathol. 60, 1057 (2007). (Pubitemid 47441942)
69. Bates, C. S., Montanez, G. E., Woods, C. R., Vincent, R. M. & Eichenbaum, Z. Identification and characterization of a Streptococcus pyogenes operon involved in binding of hemoproteins and acquisition of iron. Infect. Immun. 71, 1042-1055 (2003). (Pubitemid 36254283)
70. Eichenbaum, Z., Muller, E., Morse, S. A. & Scott, J. R. Acquisition of iron from host proteins by the group A Streptococcus. Infect. Immun. 64, 5428-5429 (1996). (Pubitemid 26404017)
71. Engleberg, N. C., Heath, A., Vardaman, K. & DiRita, V. J. Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect. Immun. 72, 623-628 (2004). (Pubitemid 38166637)
72. Fontaine, M. C., Lee, J. J. & Kehoe, M. A. Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect. Immun. 71, 3857-3865 (2003). (Pubitemid 36753709)
73. Sierig, G., Cywes, C., Wessels, M. R. & Ashbaugh, C. D. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci. Infect. Immun. 71, 446-455 (2003). (Pubitemid 36026049)
74. Ofek, I., Zafriri, D., Goldhar, J. & Eisenstein, B. I. Inability of toxin inhibitors to neutralize enhanced toxicity caused by bacteria adherent to tissue culture cells. Infect. Immun. 58, 3737-3742 (1990). (Pubitemid 20353377)
75. Smeesters, P. R., McMillan, D. J. & Sriprakash, K. S. The streptococcal M protein: a highly versatile molecule. Trends Microbiol. 18, 275-282 (2010).
76. Ginsburg, I. Could synergistic interactions among reactive oxygen species, proteinases, membraneperforating enzymes, hydrolases, microbial hemolysins and cytokines be the main cause of tissue damage in infectious and inflammatory conditions? Med. Hypotheses 51, 337-346 (1998). (Pubitemid 28494031)
77. Kwinn, L. A. & Nizet, V. How group A Streptococcus circumvents host phagocyte defenses. Future Microbiol. 2, 75-84 (2007). (Pubitemid 46766999)
78. Taylor, F. B. Jr et al. Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. Clin. Infect. Dis. 29, 167-177 (1999). (Pubitemid 29336820)
79. Miyoshi-Akiyama, T. et al. Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J. Infect. Dis. 192, 107-116 (2005). (Pubitemid 40863863)
80. Bakleh, M. et al. Correlation of histopathologic findings with clinical outcome in necrotizing fasciitis. Clin. Infect. Dis. 40, 410-414 (2005). (Pubitemid 40220347)
81. Goldmann, O., Sastalla, I., Wos-Oxley, M., Rohde, M. & Medina, E. Streptococcus pyogenes induces oncosis in macrophages through the activation of an inflammatory programmed cell death pathway. Cell. Microbiol. 11, 138-155 (2009).
82. Wexler, D. E., Chenoweth, D. E. & Cleary, P. P. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl Acad. Sci. USA 82, 8144-8148 (1985). (Pubitemid 16171050)
83. Sumby, P. et al. A Chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect. Immun. 76, 978-985 (2008). (Pubitemid 351428057)
84. Zinkernagel, A. S. et al. The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 4, 170-178 (2008).
85. Lin, A., Loughman, J. A., Zinselmeyer, B. H., Miller, M. J. & Caparon, M. G. Streptolysin S inhibits neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infect. Immun. 77, 5190-5201 (2009).
86. Harrington, D. J., Sutcliffe, I. C. & Chanter, N. The molecular basis of Streptococcus equi infection and disease. Microbes Infect. 4, 501-510 (2002). (Pubitemid 34270687)
87. Timoney, J. F. & Kumar, P. Early pathogenesis of equine Streptococcus equi infection (strangles). Equine Vet. J. 40, 637-642 (2008).
88. Bisno, A. L., Brito, M. O. & Collins, C. M. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3, 191-200 (2003). (Pubitemid 36389182)
89. Terao, Y., Kawabata, S., Nakata, M., Nakagawa, I. & Hamada, S. Molecular characterization of a novel fibronectin-binding protein of Streptococcus pyogenes strains isolated from toxic shock-like syndrome patients. J. Biol. Chem. 277, 47428-47435 (2002). (Pubitemid 36159259)
90. Joh, D., Wann, E. R., Kreikemeyer, B., Speziale, P. & Hook, M. Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol. 18, 211-223 (1999). (Pubitemid 29324737)
91. Kawabata, S. et al. Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells. Microb. Pathog. 27, 71-80 (1999). (Pubitemid 29397228)
92. Nakagawa, I., Nakata, M., Kawabata, S. & Hamada, S. Cytochrome c-mediated caspase-9 activation triggers apoptosis in Streptococcus pyogenes-infected epithelial cells. Cell. Microbiol. 3, 395-405 (2001). (Pubitemid 32600453)
93. Cywes Bentley, C., Hakansson, A., Christianson, J. & Wessels, M. R. Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling. Cell. Microbiol. 7, 945-955 (2005). (Pubitemid 40903317)
94. Klenk, M. et al. Streptococcus pyogenes serotype-dependent and independent changes in infected HEp-2 epithelial cells. ISME J. 1, 678-692 (2007). (Pubitemid 350231337)
95. Cywes, C. & Wessels, M. R. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 414, 648-652 (2001). (Pubitemid 33151261)
96. Sumitomo, T. et al. Streptolysin S contributes to group A streptococcal translocation across an epithelial barrier. J. Biol. Chem. 286, 2750-2761 (2011).
97. Fuqua, W. C., Winans, S. C. & Greenberg, E. P. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 176, 269-275 (1994). (Pubitemid 24034041)
98. Chaussee, M. S., Phillips, E. R. & Ferretti, J. J. Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion. Infect. Immun. 65, 1956-1959 (1997). (Pubitemid 27193627)
99. Griffiths, B. B. & McClain, O. The role of iron in the growth and hemolysin (Streptolysin S) production in Streptococcus pyogenes. J. Basic Microbiol. 28, 427-436 (1988).
100. Surette, M. G., Miller, M. B. & Bassler, B. L. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc. Natl Acad. Sci. USA 96, 1639-1644 (1999). (Pubitemid 29098504)
101. Lyon, W. R., Madden, J. C., Levin, J. C., Stein, J. L. & Caparon, M. G. Mutation of luxS affects growth and virulence factor expression in Streptococcus pyogenes. Mol. Microbiol. 42, 145-157 (2001). (Pubitemid 34212168)
102. Salim, K. Y., de Azavedo, J. C., Bast, D. J. & Cvitkovitch, D. G. Role for sagA and siaA in quorum sensing and iron regulation in Streptococcus pyogenes. Infect. Immun. 75, 5011-5017 (2007). (Pubitemid 47502174)
103. Kleerebezem, M. Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis. Peptides 25, 1405-1414 (2004). (Pubitemid 39221524)
104. Kihlberg, B. M., Cooney, J., Caparon, M. G., Olsen, A. & Bjorck, L. Biological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga. Microb. Pathog. 19, 299-315 (1995). (Pubitemid 26022897)
105. Federle, M. J., McIver, K. S. & Scott, J. R. A response regulator that represses transcription of several virulence operons in the group A Streptococcus. J. Bacteriol. 181, 3649-3657 (1999). (Pubitemid 29283790)
106. Heath, A., DiRita, V. J., Barg, N. L. & Engleberg, N. C. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect. Immun. 67, 5298-5305 (1999). (Pubitemid 29455305)
107. Beckert, S., Kreikemeyer, B. & Podbielski, A. Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect. Immun. 69, 534-537 (2001). (Pubitemid 32038354)
108. Kreikemeyer, B., Boyle, M. D., Buttaro, B. A., Heinemann, M. & Podbielski, A. Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component type regulators requires a small RNA molecule. Mol. Microbiol. 39, 392-406 (2001). (Pubitemid 32113511)
109. Molinari, G. et al. The role played by the group A streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol. Microbiol. 40, 99-114 (2001). (Pubitemid 32322865)
110. Shelburne, S. A. et al. A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection. PLoS Pathog. 6, (2010).
111. Li, Z., Sledjeski, D. D., Kreikemeyer, B., Podbielski, A. & Boyle, M. D. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J. Bacteriol. 181, 6019-6027 (1999). (Pubitemid 29459912)
112. Mangold, M. et al. Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol. Microbiol. 53, 1515-1527 (2004). (Pubitemid 39209121)
113. Biswas, I., Germon, P., McDade, K. & Scott, J. R. Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect. Immun. 69, 7029-7038 (2001). (Pubitemid 32995463)
114. Cotter, P. D. et al. Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes. PLoS Pathog. 4 e1000144 (2008). The discovery of LLS, the first non-streptococcal SLS-like peptide to be described. This discovery confirms the existence of an extended family of SLS-like disease-promoting toxins within the TOMM family.
115. Melby, J. O., Nard, N. J. & Mitchell, D. A. Thiazole/oxazole-modified microcins: ribosomal templates for complex natural products. Curr. Opin. Chem. Biol. 15, 369-378 (2011).
116. Sudek, S., Haygood, M. G., Youssef, D. T. & Schmidt, E. W. Structure of trichamide, a cyclic peptide from the bloom-forming cyanobacterium Trichodesmium erythraeum, predicted from the genome sequence. Appl. Environ. Microbiol. 72, 4382-4387 (2006). (Pubitemid 43894908)
117. Haft, D. H. A strain-variable bacteriocin in Bacillus anthracis and Bacillus cereus with repeated Cys-Xaa-Xaa motifs. Biol. Direct 4, 1-5 (2009).
118. Donia, M. S. et al. Natural combinatorial peptide libraries in cyanobacterial symbionts of marine ascidians. Nature Chem. Biol. 2, 729-735 (2006). (Pubitemid 44764216)
119. Li, B. et al. Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc. Natl Acad. Sci. USA 107, 10430-10435 (2010).
120. Schmidt, E. W. Trading molecules and tracking targets in symbiotic interactions. Nature Chem. Biol. 4, 466-473 (2008). (Pubitemid 352019761)
121. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
122. Schmidt, E. W. et al. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl Acad. Sci. USA 102, 7315-7320 (2005). (Pubitemid 40696376)
123. Onaka, H., Tabata, H., Igarashi, Y., Sato, Y. & Furumai, T. Goadsporin, a chemical substance which promotes secondary metabolism and morphogenesis in streptomycetes. I. Purification and characterization. J. Antibiot. (Tokyo) 54, 1036-1044 (2001). (Pubitemid 34110872)
124. McIntosh, J. A., Donia, M. S. & Schmidt, E. W. Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds. Nature Prod. Rep. 26, 537-559 (2009).
125. Lecuit, M. Human listeriosis and animal models. Microbes Infect. 9, 1216-1225 (2007). (Pubitemid 47375149)
126. Linnen, M. J. et al. Epidemic listeriosis associated with Mexican-style cheese. N. Engl. J. Med. 319, 823-828 (1988).
127. Wiedmann, M. et al. Ribotypes and virulence gene polymorphisms suggest three distinct Listeria monocytogenes lineages with differences in pathogenic potential. Infect. Immun. 65, 2707-2716 (1997). (Pubitemid 27264098)
128. Jeffers, G. T. et al. Comparative genetic characterization of Listeria monocytogenes isolates from human and animal listeriosis cases. Microbiology 147, 1095-1104 (2001). (Pubitemid 32454628)
129. Gray, M. J. et al. Listeria monocytogenes isolates from foods and humans form distinct but overlapping populations. Appl. Environ. Microbiol. 70, 5833-5841 (2004). (Pubitemid 39471824)
130. Schnupf, P. & Portnoy, D. A. Listeriolysin O: a phagosome-specific lysin. Microbes Infect. 9, 1176-1187 (2007). (Pubitemid 47375145)
131. Gaillard, J. L., Berche, P. & Sansonetti, P. Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect. Immun. 52, 50-55 (1986). (Pubitemid 16137678)
132. Clayton, E. M., Hill, C., Cotter, P. D. & Ross, R. P. Realtime PCR assay to differentiate listeriolysin S-positive and-negative strains of Listeria monocytogenes. Appl. Environ. Microbiol. 77, 163-171 (2011).
133. Pei, J. & Grishin, N. V. Type II CAAX prenyl endopeptidases belong to a novel superfamily of putative membrane-bound metalloproteases. Trends Biochem. Sci. 26, 275-277 (2001). (Pubitemid 32436370)
134. Lopez, S., Marco, A. J., Prats, N. & Czuprynski, C. J. Critical role of neutrophils in eliminating Listeria monocytogenes from the central nervous system during experimental murine listeriosis. Infect. Immun. 68, 4789-4791 (2000). (Pubitemid 30497758)
135. Fitzgerald, J. R. et al. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J. Bacteriol. 183, 63-70 (2001). (Pubitemid 32003108)
136. Smith, L. A. Botulism and vaccines for its prevention. Vaccine 27 (Suppl. 4), D33-D39 (2009).
137. Judicial Commission of the International Committee on Systematic Bacteriology. Rejection of Clostridium putrificum and conservation of Clostridium botulinum and Clostridium sporogenes - Opinion 69. Int. J. Syst. Bacteriol. 49, 339 (1999).
138. Sebaihia, M. et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res. 17, 1082-1092 (2007). (Pubitemid 47026355)
139. Severinov, K., Semenova, E., Kazakov, A., Kazakov, T. & Gelfand, M. S. Low-molecular-weight posttranslationally modified microcins. Mol. Microbiol. 65, 1380-1394, (2007).
140. Morris, R. P. et al. Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu. J. Am. Chem. Soc. 131, 5946-5955 (2009).
141. Wang, J. et al. Identification and analysis of the biosynthetic gene cluster encoding the thiopeptide antibiotic cyclothiazomycin in Streptomyces hygroscopicus 10-22. Appl. Environ. Microbiol. 76, 2335-2344 (2010).
142. McIntosh, J. A. & Schmidt, E. W. Marine molecular machines: heterocyclization in cyanobactin biosynthesis. Chembiochem 11, 1413-1421 (2010).
143. Onaka, H., Nakaho, M., Hayashi, K., Igarashi, Y. & Furumai, T. Cloning and characterization of the goadsporin biosynthetic gene cluster from Streptomyces sp. TP-A0584. Microbiology 151, 3923-3933 (2005). (Pubitemid 41829972)
144. Igarashi, Y. et al. Goadsporin, a chemical substance which promotes secondary metabolism and morphogenesis in streptomycetes. II. Structure determination. J. Antibiot. (Tokyo) 54, 1045-1053 (2001). (Pubitemid 34110873)
145. Pestka, S. & Brot, N. Studies on the formation of transfer ribonucleic acid-ribosome complexes. IV. Effect of antibiotics on steps of bacterial protein synthesis: some new ribosomal inhibitors of translocation. J. Biol. Chem. 246, 7715-7722 (1971).
146. Bagley, M. C., Dale, J. W., Merritt, E. A. & Xiong, X. Thiopeptide antibiotics. Chem. Rev. 105, 685-714 (2005). (Pubitemid 40351637)
147. Hughes, R. A. & Moody, C. J. From amino acids to heteroaromatics- thiopeptide antibiotics, nature's heterocyclic peptides. Angew. Chem. Int. Ed. Engl. 46, 7930-7954 (2007). (Pubitemid 350033464)
148. Williams, A. B. & Jacobs, R. S. A marine natural product, patellamide D, reverses multidrug resistance in a human leukemic cell line. Cancer Lett. 71, 97-102 (1993). (Pubitemid 23251980)
149. Long, P. F., Dunlap, W. C., Battershill, C. N. & Jaspars, M. Shotgun cloning and heterologous expression of the patellamide gene cluster as a strategy to achieving sustained metabolite production. Chembiochem 6, 1760-1765 (2005). (Pubitemid 41475266)
150. Chen, X. H. et al. Genome analysis of Bacillus amyloliquefaciens FZB42 reveals its potential for biocontrol of plant pathogens. J. Biotechnol. 140, 27-37 (2009).
151. Scholz, R. et al. Plantazolicin, a novel microcin B17/streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42. J. Bacteriol. 193, 215-224 (2010).
152. Schmidt, E. W. The hidden diversity of ribosomal peptide natural products. BMC Biol. 8, 83 (2010).
153. Dale, J. B., Chiang, E. Y., Hasty, D. L. & Courtney, H. S. Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci. Infect. Immun. 70, 2166-2170 (2002). (Pubitemid 34242219)
154. Bernheimer, A. W. Formation of a bacterial toxin (streptolysin S) by resting cells. J. Exp. Med. 90, 373-392 (1949).
155. Koyama, J. Biochemical studies on Streptolysin S'. II. Properties of a polypeptide component and its role in the toxin activity. J. Biochem. 54, 146-151 (1963).
156. Koyama, J. Biochemical studies on Streptolysin S'. IV. Properties of the oligoribonucleotide portion. J. Biochem. 56, 355-360 (1964).
157. Koyama, J. & Egami, F. Biochemical studies on streptolysin S' formed in the presence of yeast ribonucleic acid. I. The purification and some properties of the toxin. J. Biochem. 53, 147-154 (1963).
158. Bernheimer, A. W. Physical behavior of streptolysin S. J. Bacteriol. 93, 2024-2025 (1967).
159. Kelleher, N. L., Hendrickson, C. L. & Walsh, C. T. Posttranslational heterocyclization of cysteine and serine residues in the antibiotic microcin B17: distributivity and directionality. Biochemistry 38, 15623-15630 (1999). (Pubitemid 129503605)
160. Roy, R. S., Allen, O. & Walsh, C. T. Expressed protein ligation to probe regiospecificity of heterocyclization in the peptide antibiotic microcin B17. Chem. Biol. 6, 789-799 (1999).